The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
According to AbbVie's latest financial reports the company's current earnings are NZ$55.00 Billion. In 2023 the company made an earning of NZ$10.64 Billion a decrease over its 2022 earnings that were of NZ$22.95 Billion. The earnings displayed on this page is the company's Pretax Income.